Biosimilars, Vaccines, Contract Manufacturing

Nanolek is dedicated to advancing healthcare through the development and production of innovative biotechnological products, particularly focusing on vaccines and treatments for various diseases. The company emphasizes the importance of children's vaccines, which are included in the National Immunization Program of the Russian Federation. Their product portfolio also encompasses medications for oncological, autoimmune, and orphan diseases, showcasing a commitment to addressing critical health challenges. Notable products include the pneumococcal vaccine Pneumotex®, the combined vaccine Pentaxim®, and the HPV vaccine Tsegardex®, which is currently undergoing clinical trials for children and adolescents.

To ensure technological sovereignty and enhance production capabilities, Nanolek has shifted towards collaboration with local suppliers and manufacturers, particularly in the Kirov region. This initiative includes the introduction of alternative raw material sources and the development of local engineering solutions to replace foreign technology components. The company has also invested in upgrading its production lines to improve efficiency and maintain high standards of sterility. By focusing on domestic production and innovation, Nanolek aims to strengthen its position in the pharmaceutical market while contributing to the broader goal of import substitution in Russia.

Russia

Nanolek is a Russian fast-growing pharmaceutical company which aims to become one of the market leaders in the production of innovative biotechnological products and modern vaccines, stimulating the creation of the national bioeconomy and amplifying the country’s biosafety.
Nanolek’s product portfolio is formed in compliance with the priority therapeutic areas: cardiological and oncological products, innovative vaccines, including the cell-based influenza vaccine and the first Russian inactivated polio vaccine. In the meantime the company is also developing a number of biotech products, including new to the Russian market modern vaccines.

Nanolek

Company Details